ArticleOncogenesis2016

A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors.

Y Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.